ConductScience.org, home
Papers
API referenceFor AI assistants

Paper · 36916531

Do patients with metastatic pancreatic adenocarcinoma to the lung have improved survival?

Ebrahimi A and 6 others. Cancer Med, 2023. Cited by 10 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Do patients with metastatic pancreatic adenocarcinoma to the lung have improved survival? Papers, record 36916531. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36916531

On this page

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Do patients with metastatic pancreatic adenocarcinoma to the lung have improved survival?
PubMed
Journal
Cancer Med
PubMed
Year
2023
PubMed
Publication types
Journal Article, Research Support, N.I.H., Extramural
PubMed
Citations, by iCite
10
iCite
Relative citation ratio, by iCite
0.69
iCite
Revised in PubMed
2024-09-23
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Ebrahimi AArenhttps://orcid.org/0000-0001-7304-2621
2Cham JJason
3Puglisi LLeah
4De Shadarevian MMelanie
5Hermel DJDavid J
6Spierling Bagsic SRSamantha R
7Sigal DDarren

Source PubMed

Topics8

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Pancreatic NeoplasmsMajor topic
AdenocarcinomaMajor topic
Carcinoma, Pancreatic DuctalMajor topic
Lung NeoplasmsMajor topic
Humans
Prognosis
Lung
Retrospective Studies

Source PubMed

Grants2

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
KL2 TR002552NCATS NIH HHSUnited StatesKL2TR002552PubMed and NIHNIH RePORTER
UL1 TR002550NCATS NIH HHSUnited StatesUL1TR002550PubMed and NIHNIH RePORTER

Trials0

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

None in this release.

Comments and corrections0

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

None in this release.

References26

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
131,673,783Initial pulmonary metastasis after pancreatectomy for pancreatic ductal adenocarcinoma.Surg Today2020https://conductscience.org/library/papers/31673783PubMed
229,427,136Molecular Alterations Associated with DNA Repair in Pancreatic Adenocarcinoma Are Associated with Sites of Recurrence.J Gastrointest Cancer2019https://conductscience.org/library/papers/29427136PubMed
330,834,048Epidemiology of Pancreatic Cancer: Global Trends, Etiology and Risk Factors.World J Oncol2019https://conductscience.org/library/papers/30834048PubMed
428,129,987Comparison of adjuvant gemcitabine and capecitabine with gemcitabine monotherapy in patients with resected pancreatic cancer (ESPAC-4): a multicentre, open-label, randomised, phase 3 trial.Lancet2017https://conductscience.org/library/papers/28129987PubMed
534,503,261Genomic Heterogeneity of Pancreatic Ductal Adenocarcinoma and Its Clinical Impact.Cancers (Basel)2021https://conductscience.org/library/papers/34503261PubMed
627,856,064Radical surgery of oligometastatic pancreatic cancer.Eur J Surg Oncol2017https://conductscience.org/library/papers/27856064PubMed
730,865,919Pancreatic Adenocarcinoma, Version 1.2019.J Natl Compr Canc Netw2019https://conductscience.org/library/papers/30865919PubMed
832,593,337Pancreatic cancer.Lancet2020https://conductscience.org/library/papers/32593337PubMed
928,338,509Patterns, Timing, and Predictors of Recurrence Following Pancreatectomy for Pancreatic Ductal Adenocarcinoma.Ann Surg2018https://conductscience.org/library/papers/28338509PubMed
1031,861,620Metastasis in Pancreatic Ductal Adenocarcinoma: Current Standing and Methodologies.Genes (Basel)2019https://conductscience.org/library/papers/31861620PubMed

1 to 10 of 26

See all 26 references

Cited by11

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 10 citations.

PMIDTitleJournalYearIn PapersSource
42,979,207Liver-Lung Organotropism in Pancreatic Ductal Adenocarcinoma: A Five-Stage Framework.Cancer Manag Res2026https://conductscience.org/library/papers/42979207PubMed
42,474,769Survival after pulmonary metastasectomy for pancreatobiliary carcinomas: insights from a nationwide multicenter database.Surg Today2026https://conductscience.org/library/papers/42474769PubMed
42,036,595Pulmonary Metastases After Surgical Resection of Pancreatic Ductal Adenocarcinoma: Impact on Long-Term Survival and Perspectives on Targeted Treatments.Ann Surg Oncol2026https://conductscience.org/library/papers/42036595PubMed
41,889,072Initial Site of Metastasis Influences Prognosis in Pancreatic Ductal Adenocarcinoma.Cancer Med2026https://conductscience.org/library/papers/41889072PubMed
41,524,824What we can learn from the lepidic growth pattern of pulmonary metastases.Clin Exp Metastasis2026https://conductscience.org/library/papers/41524824PubMed
40,760,262Can Machine Learning Predict Metastatic Sites in Pancreatic Ductal Adenocarcinoma? A Radiomic Analysis.J Imaging Inform Med2026https://conductscience.org/library/papers/40760262PubMed
40,469,173Risk and prognostic factors of survival for patients with pancreatic ductal adenocarcinoma metastasis to lung: a cohort study.Front Oncol2025https://conductscience.org/library/papers/40469173PubMed
38,791,002Dysbiosis Signature of Fecal Microbiota in Patients with Pancreatic Adenocarcinoma and Pancreatic Intraductal Papillary Mucinous Neoplasms.Biomedicines2024https://conductscience.org/library/papers/38791002PubMed
38,393,682Mesothelin CAR T Cells Secreting Anti-FAP/Anti-CD3 Molecules Efficiently Target Pancreatic Adenocarcinoma and its Stroma.Clin Cancer Res2024https://conductscience.org/library/papers/38393682PubMed
37,892,585Unexpected and Rare Sites of Metastasis in Oncologic Patients.J Clin Med2023https://conductscience.org/library/papers/37892585PubMed

1 to 10 of 11

See all 11 cited by

Genes5

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
FOXA13,169PubTator's text mininghttps://conductscience.org/library/genes/3169NCBI Gene
KRAS3,845PubTator's text mininghttps://conductscience.org/library/genes/3845NCBI Gene
PTEN5,728PubTator's text mininghttps://conductscience.org/library/genes/5728NCBI Gene
SHH6,469PubTator's text mininghttps://conductscience.org/library/genes/6469NCBI Gene
TENM110,178PubTator's text mininghttps://conductscience.org/library/genes/10178NCBI Gene

Drugs0

The drugs whose trials, in the Pipelines release, list the paper.

None in this release.

Data0

The data bank entries PubMed's record names. Trial numbers are under Trials.

None in this release.

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/36916531

GET https://conductscience.org/api/papers/v1/36916531/references?page=2

API referenceFor AI assistants